Sugi Predict

Sugi Predict / Compounds / SCHEMBL571353

SCHEMBL571353

SCHEMBL571353

CC1=C(C)C(=O)c2cc(C)ccc2C1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 2/20 1.00
▸ MAOB P27338 2/20 1.00
▸ ELANE P08246 1/20 0.71
▸ LCK P06239 1/20 0.52
▸ CA1 P00915 1/20 0.48
▸ CA2 P00918 1/20 0.48
▸ CA4 P22748 1/20 0.48
▸ CA7 P43166 1/20 0.48
▸ CA9 Q16790 1/20 0.48
▸ NQO1 P15559 3/20 0.47
▸ POR P16435 3/20 0.47
▸ ALKBH3 Q96Q83 2/20 0.46
▸ USP8 P40818 1/20 0.46
▸ USP7 Q93009 1/20 0.46
▸ POLB P06746 1/20 0.44
▸ METAP1 P53582 2/20 0.44
▸ BCL2 P10415 1/20 0.43
▸ MCL1 Q07820 1/20 0.43
▸ CDC25A P30304 1/20 0.41
▸ CDC25B P30305 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30905230 1.00 MAOA (1.00) MAOAMAOBELANELCKCA1
SCHEMBL182959 0.90 ELANE (0.86) MAOAMAOBELANELCKCA1
SCHEMBL583153 0.90 ELANE (0.86) MAOAMAOBELANELCKCA1
SCHEMBL22799422 0.85 ELANE (0.78) MAOAMAOBELANELCKCA1
SCHEMBL23271984 0.85 MAOA (0.73) MAOAMAOBELANELCKCA1
SCHEMBL9628207 0.85 MAOA (0.73) MAOAMAOBELANELCKCA1
SCHEMBL30003553 0.85 MAOA (0.73) MAOAMAOBELANELCKCA1
SCHEMBL12108763 0.84 MAOA (0.73) MAOAMAOBELANELCKCA1
SCHEMBL2610165 0.84 ELANE (0.77) MAOAMAOBELANELCKCA1
SCHEMBL4401141 0.84 ELANE (0.77) MAOAMAOBELANELCKCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119322138-A Evaluation method for baking aroma of cigarette smoke and application thereof 云南中烟工业有限责任公司 2025-01-17 — — CN claimed
CN-119291085-A Evaluation method for sweet aroma of cigarette smoke and application thereof 云南中烟工业有限责任公司 2025-01-10 — — CN claimed
CN-118001879-A Application of nano copper alloy in filtering harmful substances in cigarette smoke 广东合一新材料研究院有限公司 2024-05-10 — — CN claimed
CN-105985912-B Alternaria alternata and application thereof 郝勋 2019-12-24 — — CN claimed
CN-105985912-A Alternaria alternata and application thereof 郝勋 2016-10-05 — — CN claimed
CN-119322138-A Evaluation method for baking aroma of cigarette smoke and application thereof 云南中烟工业有限责任公司 2025-01-17 — — CN disclosed
CN-119291085-A Evaluation method for sweet aroma of cigarette smoke and application thereof 云南中烟工业有限责任公司 2025-01-10 — — CN disclosed
CN-119198957-A Evaluation method for nut aroma of cigarette smoke and application of evaluation method 云南中烟工业有限责任公司 2024-12-27 — — CN disclosed
CN-118001879-A Application of nano copper alloy in filtering harmful substances in cigarette smoke 广东合一新材料研究院有限公司 2024-05-10 — — CN disclosed
CN-118010834-A Method for carrying out online detection on flue gas by utilizing microwave plasma torch mass spectrum 浙江大学 2024-05-10 — — CN disclosed
US-11613509-B2 Radical polymerization control agent and radical polymerization control method KAWASAKI KASEI CHEMICALS LTD. (JP) 2023-03-28 — — US disclosed
CN-110891980-B Radical polymerization control agent and radical polymerization control method 川崎化成工业株式会社 2022-09-30 — — CN disclosed
CN-104207324-A Tobacco leaf processing method CHINA TOBACCO GUIZHOU IND CO 2014-12-17 — — CN disclosed
CN-103849467-A Method for preparing tobacco flavor through maillard reaction with tobacco flower buds as raw material CHINA TOBACCO HENAN IND CO LTD 2014-06-11 — — CN disclosed
US-20130345312-A1 TREATMENT OF MITOCHONDRIAL DISEASES WITH NAPHTHOQUINONES BIOELECTRON TECHNOLOGY CORPORATION 2013-12-26 — — US disclosed
EP-2600857-A2 TREATMENT OF MITOCHONDRIAL DISEASES WITH NAPHTHOQUINONES Edison Pharmaceuticals, Inc. (US) 2013-06-12 — — EP disclosed
WO-2012019029-A2 TREATMENT OF MITOCHONDRIAL DISEASES WITH NAPHTHOQUINONES EDISON PHARMACEUTICALS, INC. (US) 2012-02-09 — — WO disclosed
CN-100456971-C Biological tobacco leaf reproduced by rolling process HANZHONG CIGARETTE 2 FACTORY (CN) 2009-02-04 — — CN disclosed
WO-2006107827-A1 SKIN BONDING PROCESS CREIGHTON UNIVERSITY (US) 2006-10-12 — — WO disclosed
CN-1775118-A Biological tobacco leaf reproduced by rolling process HANZHONG CIGARETTE 2 FACTORY (CN) 2006-05-24 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11613509-B2 Radical polymerization control agent and radical polymerization control method PPOX, NOX4, CROCC MAOA 204/4885MAOB 358/4885ELANE 4115/4885
US-20130345312-A1 TREATMENT OF MITOCHONDRIAL DISEASES WITH NAPHTHOQUINONES NDUFAB1, NDUFA2, NDUFS6 MAOA 432/4885MAOB 880/4885ELANE 408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.